MTAP and lung adenocarcinoma: Among a total of 200 patients, we identified a cohort of 72 patients with lung adenocarcinoma (LUAD) who were treated with pemetrexed plus carboplatin and had tumor RNA expression data on both the MTAP and CDKN2A genes (Fig. 4a).